Q2 FY2025 Earnings
Financial report interval: 2025.03.30 - 2025.06.30
Overview: Vigil Neuroscience(VIGL) the EBIT is -27.49 M (-22.3%);the EPS is -0.56 (-7.02%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.03B22.30%
----
----
EPS
-0.567.02%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf